Gupta Punkaj, Carlson Jacob, Wells Dennis, Selakovich Patrick, Robertson Michael J, Gossett Jeffrey M, Fontenot Eudice E, Steiner Matthew B
Division of Pediatric Cardiology, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Division of Critical Care, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Artif Organs. 2015 Apr;39(4):369-74. doi: 10.1111/aor.12379. Epub 2014 Oct 8.
The effects of extracorporeal membrane oxygenation (ECMO) support on renal function in children with critical illness are unknown. The objective of this study was to investigate the impact of ECMO on renal function among children in different age groups. We performed a single-center retrospective observational study in critically ill children ≤ 18 years supported on ECMO for refractory cardiac or pulmonary failure (2006-2012). The patient population was divided into four age groups for the purpose of comparisons. The Acute Kidney Injury Network's (AKIN's) validated, three-tiered staging system for acute kidney injury was used to categorize the degree of worsening renal function. Data on patient demographics, baseline characteristics, renal function parameters, dialysis, ultrafiltration, duration of mechanical cardiac support, and mortality were collected. Comparisons of baseline characteristics, duration of mechanical cardiac support, and renal function were made between the four age groups. During the study period, 311 patients qualified for inclusion, of whom 289 patients (94%) received venoarterial (VA) ECMO, 12 (4%) received venovenous (VV) ECMO, and 8 (3%) received both VV and VA ECMO. A total of 109 patients (36%) received ultrafiltration on ECMO, 58 (19%) received hemodialysis, and 51 (16%) received peritoneal dialysis. There was a steady and sustained improvement in renal function in all age groups during the ECMO run, with the maximum and longest-sustained improvement occurring in the oldest age group. Proportions of patients in different AKIN stages remained similar in the first 7 days after ECMO initiation. We demonstrate that renal dysfunction improves early after ECMO support. Irrespective of the underlying disease process or patient age, renal function improves in children with pulmonary or cardiac failure who are placed on ECMO.
体外膜肺氧合(ECMO)支持对危重症儿童肾功能的影响尚不清楚。本研究的目的是调查ECMO对不同年龄组儿童肾功能的影响。我们对2006年至2012年因难治性心功能或肺功能衰竭接受ECMO支持的18岁及以下危重症儿童进行了一项单中心回顾性观察研究。为了进行比较,将患者人群分为四个年龄组。采用急性肾损伤网络(AKIN)验证的急性肾损伤三级分期系统对肾功能恶化程度进行分类。收集了患者人口统计学、基线特征、肾功能参数、透析、超滤、机械心脏支持持续时间和死亡率等数据。对四个年龄组的基线特征、机械心脏支持持续时间和肾功能进行了比较。在研究期间,311例患者符合纳入标准,其中289例(94%)接受了静脉-动脉(VA)ECMO,12例(4%)接受了静脉-静脉(VV)ECMO,8例(3%)同时接受了VV和VA ECMO。共有109例患者(36%)在ECMO期间接受了超滤,58例(19%)接受了血液透析,51例(16%)接受了腹膜透析。在ECMO运行期间,所有年龄组的肾功能都有稳定且持续的改善,最大且持续时间最长的改善出现在年龄最大的组。在启动ECMO后的前7天,不同AKIN分期的患者比例保持相似。我们证明,ECMO支持后早期肾功能障碍得到改善。无论潜在疾病过程或患者年龄如何,接受ECMO的心力衰竭或肺衰竭儿童的肾功能都会改善。